http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012502284-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2009-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012502284-A |
| titleOfInvention | YKL-40 as a selectable marker for disease treatment and monitoring |
| abstract | 【Task】 The present invention selects a treatment for a particular disease or disorder by determining the level of YKL-40 in a sample obtained from a subject and comparing the level to one or more YKL-40 reference levels. And a method for monitoring therapeutic treatment of a particular disease or disorder and a method for determining the prognosis of a patient before, during and after treatment. The reference level is generally a level obtained from a healthy subject or a level obtained in the past from the same subject. The invention further relates to kits and instruments that can be used in the methods of the invention. [Selection] |
| priorityDate | 2008-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 373.